SGB in Management of Patients With PDPH Using TCD

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

May 24, 2020

Primary Completion Date

September 20, 2020

Study Completion Date

September 20, 2020

Conditions
Post-Dural Puncture Headache
Interventions
DRUG

Sphenopalatine Ganglion Block using 2% lidocaine

Sphenopalatine Ganglion Block is performed by a hollow culture swab that is connected with a 21-gauge syringe filled with three ml 2% lidocaine, inserted parallel to the floor of the nose until resistance is felt. The swab is at the posterior pharyngeal wall superior to the middle turbinate. The applicator was kept in the nostril for five to ten mins. The same procedure is done also in the second nostril. The patients are then examined by TCD.

Trial Locations (1)

44519

Faculty of Medicine, Zagazig University, Zagazig

All Listed Sponsors
lead

Zagazig University

OTHER_GOV

NCT04401878 - SGB in Management of Patients With PDPH Using TCD | Biotech Hunter | Biotech Hunter